Eris Lifesciences Limited
₹1,352.75
INR+23.60(+1.78%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹17623.67 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹20624.64 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
50.53
Forward P/E
Price to Earnings ratio based on forecasted earnings
31.24
PEG Ratio
Price/Earnings to Growth ratio
31.24
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
7.09
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
74.79%
Operating Margin
Operating income as a percentage of revenue
24.90%
Return on Equity
Net income as a percentage of shareholders' equity
13.09%
Revenue (TTM)
Total revenue over trailing 12 months
₹2485.29 Cr+47.599999999999994%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹863.98 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹25.53-25.8%
Balance Sheet
Total Cash
Total cash and short-term investments
₹242.55 Cr
Total Debt
Total short-term and long-term debt
₹2734.83 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
86.08%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹809.15 - ₹1522.05
Beta
Measure of stock's volatility compared to the market
0.30
Shares Outstanding
Total number of shares issued by the company
₹13.61 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
2.23%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
0.00%